Related Experiment Videos
Experience-based group education in Type 2 diabetes: a randomised controlled trial.
Anna Sarkadi1, Urban Rosenqvist
1Department of Public Health and Caring Sciences, Uppsala University, Uppsala Science Park, Uppsala SE-751 85, Sweden. Anna.Sarkadi@pubcare.uu.se
Patient Education and Counseling
|June 10, 2004
Summary
An experience-based educational program significantly improved glycaemic control in Type 2 diabetes patients, lowering HbA1c by 0.4% at 24 months. This intervention demonstrated long-term effectiveness in managing blood glucose levels.
Area of Science:
- Endocrinology
- Diabetes Management
- Health Education
Background:
- Few studies assess long-term ( > 6 months) effects of educational interventions on Type 2 diabetes glycaemic control.
- Experience-based learning is a novel approach for diabetes self-management.
Purpose of the Study:
- To evaluate the 24-month effectiveness of an experience-based group educational program for Type 2 diabetes.
- To identify mediators influencing glycaemic outcomes in Type 2 diabetes patients.
Main Methods:
- Randomized controlled trial with 77 participants with Type 2 diabetes.
- A year-long, pharmacist-led, group intervention focused on participants' glucose regulation experiences.
- HbA1c measured at baseline, 6, 12, and 24 months; questionnaires administered at baseline and follow-up.
Main Results:
- The intervention group showed a significant 0.4% decrease in HbA1c at 24 months post-intervention.
- Increased exercise and improved prediction of blood glucose levels were observed in the intervention group.
- Initial HbA1c, satisfaction with diabetes knowledge, and treatment satisfaction correlated with glycaemic outcomes.
Conclusions:
- Experience-based group education effectively reduced HbA1c in Type 2 diabetes patients long-term.
- The intervention showed an initial effect, followed by a relapse and a subsequent significant decrease at 24 months, highlighting the need for extended follow-up.
- Both biomedical and subjective factors contribute to glycaemic control variance in Type 2 diabetes.